Novozymes B A/S | 437.60 / -1.04% |
Date/Time | 05/18 / 00:00 |
Chg. / Chg.(%) | -4.60 / -1.04% |
Bid | 434.10 |
Ask | 434.60 |
Open | 442.40 |
Previous Close | 442.20 |
High | 446.10 |
Low | 429.70 |
Volume [DKK] | 124,543,049.40 |
Volume [Units] | 295,182 |
Price fixings | 2484 |
ISIN | DK0060336014 |
Security | NZYM/B |
Exchange | OMX Nordic |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 422.30 | ![]() |
106,079 |
London Inter.. | 422.60 | ![]() |
4,988 |
Turquoise | 422.30 | ![]() |
4,132 |
TradeGate | 56.760 | ![]() |
449 |
gettex | 56.580 | ![]() |
305 |
Cboe Europe .. | 429.75 | ![]() |
151 |
Frankfurt | 57.2800 | ![]() |
0 |
München | 57.76 | ![]() |
0 |
Düsseldorf | 57.10 | ![]() |
0 |
Berlin | 56.76 | ![]() |
0 |
Vienna Globa.. | 57.58 | ![]() |
0 |
Quotrix | 58.1200 | ![]() |
|
Stuttgart | 57.840 | ![]() |
|
Lang & Schwa.. | 56.70 | ![]() |
|
OMX Nordic | 437.60 | ![]() |
295,182 |
Cboe Europe .. | 434.80 | 125 | |
Nasdaq Other.. | 60.6000 | 566 | |
Xetra | 59.36 | 5 | |
Mexico | 1,305.94 | ![]() |
728 |
News
- NMD Pharma Raises €35 Million in a new Financing
02/15/2022 / 13:00 - GlobeNewswire - NMD Pharma Raises €35 Million in a new Financing
02/15/2022 / 07:00 - GlobeNewswire - Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
02/01/2022 / 08:01 - GlobeNewswire - CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO
12/20/2021 / 14:30 - GlobeNewswire - Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹
12/16/2021 / 14:00 - GlobeNewswire